Rivaroxaban, an oral direct factor Xa inhibitor

JP Piccini, MR Patel, KW Mahaffey… - Expert opinion on …, 2008 - Taylor & Francis
Rivaroxaban is a small molecule, direct Factor Xa inhibitor and may be a potentially
attractive alternative to vitamin K antagonists. Rivaroxaban is being investigated for the …
被引用次数：79 相关文章

Rivaroxaban, an oral direct factor Xa inhibitor

JP Piccini, MR Patel, KW Mahaffey… - Expert opinion on …, 2008 - pubmed.ncbi.nlm.nih.gov
Rivaroxaban is a small molecule, direct Factor Xa inhibitor and may be a potentially
attractive alternative to vitamin K antagonists. Rivaroxaban is being investigated for the …

[引用][C] Rivaroxaban, an oral direct factor Xa inhibitor

JP Piccini, MR Patel, KW Mahaffey, KAA Fox… - Expert Opinion on …, 2008 - cir.nii.ac.jp
Rivaroxaban, an oral direct factor Xa inhibitor | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …

Rivaroxaban, an oral direct factor Xa inhibitor

JP Piccini, MR Patel, KW Mahaffey… - Expert opinion on …, 2008 - research.ed.ac.uk
Rivaroxaban is a small molecule, direct Factor Xa inhibitor and may be a potentially
attractive alternative to vitamin K antagonists. Rivaroxaban is being investigated for the …

Rivaroxaban, an oral direct factor Xa inhibitor.

JP Piccini, MR Patel, KW Mahaffey, KA Fox… - Expert Opinion on …, 2008 - europepmc.org
Rivaroxaban is a small molecule, direct Factor Xa inhibitor and may be a potentially
attractive alternative to vitamin K antagonists. Rivaroxaban is being investigated for the …